Volume 40, Issue 2 pp. 111-115
Full Access

Interaction of Memantine with Cholecystokinin Receptors in Mouse Brain

E. J. Verspohl

Corresponding Author

E. J. Verspohl

Lehrstuhl Pharmakologie, Pharmazeutisches Institut der Universität Tübingen, Auf der Morgenstelle 8, D-7400 Tübingen, West Germany

Lehrstuhl Pharmakologie, Pharmazeutisches Institut der Universitat Tubingen, Auf der Morgenstelle 8, D-7400 Tübingen, West Germany.Search for more papers by this author
R. Koch

R. Koch

Merz & Co, Frankfurt, West Germany

Search for more papers by this author
W. Schatton

W. Schatton

Merz & Co, Frankfurt, West Germany

Search for more papers by this author
First published: February 1988
Citations: 5

Abstract

Abstract— The effect of memantine on CCK receptors in mouse brain has been investigated using particles of dissected cortex and striatum. Total binding of radio-labelled CCK33 was one-half maximal within 10 min of incubation and reached a maximum after 30 to 60 min when either cortex or striatum was used. Non-specific binding (presence of 100 μM unlabelled CCK8) was 50 to 80% of total binding at steady state conditions. CCK8 inhibited specific binding of radiolabeled CCK33 in a dose-dependent manner; the IC50 (half-maximal inhibitory concentration) was in the range 3 to 4 nM. Memantine increased CCK binding in a concentration-dependent manner, though at high concentrations. The EC50 (half-maximal effective concentration) of this effect was < 100 μM. The memantine effect is not due to an inhibition of labelled CCK degradation in the medium. The effect of memantine on CCK binding is unique for brain since it was not observed in pancreatic acinar membranes. These data, therefore, suggest a modulatory effect of memantine on CCK receptors in mouse brain (cortex and striatum) particles.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.